Title: Design and evaluation of hydroxamate derivatives as metal-mediated inhibitors of a protein tyrosine kinase.
Journal: Journal of medicinal chemistry 20061214
351029-70-4 | tert-Butyl (2-cyanopropyl)carbamate | AA00CQGZ | MFCD16833881
423733-46-4 | 1-(4-Bromophenyl)-3-((3,4-dimethylphenyl)amino)propan-1-one | AA00CREC | MFCD01219846
37031-10-0 | 2-(Bicyclo[2.2.1]heptan-2-ylamino)ethanol | AA00CTKJ | MFCD14622578
37712-75-7 | D-Proline, 1-acetyl-4-hydroxy-, (4R)- (9CI) | AA00CVUD | MFCD20109731
349454-54-2 | 1(2H)-Quinolinecarboxamide,3,4-dihydro-N-phenyl-(9CI) | AA00CY3H | MFCD00729543
3682-28-8 | (4-PHENYL-4H-1,2,4-TRIAZOL-3-YL)THIO]ACETIC ACID | AA00CZQ8 | MFCD00227618
35735-41-2 | 2-tert-Butylcyclohexanamine | AA00D23U | MFCD08558493
39190-96-0 | N-(4-METHYLBENZYL)-N-PROPYLAMINE | AA00D3XX | MFCD04503863
359821-43-5 | 2-Amino-1-(4-methylpiperazin-1-yl)ethanone | AA00D591 | MFCD18968418
41341-01-9 | 1-Pyrrolidinecarbonyl chloride, 2-oxo- (9CI) | AA00D6P6 | MFCD13173551